Pharmaceutical

Cancer Monthly urges Actos users to be aware of the signs of bladder cancer

actos pioglitazone hydrochloride Cancer Monthly urges Actos users to be aware of the signs of bladder cancerCancer Monthly, an information site about the disease, is advising people who take or have taken the type 2 diabetes drug Actos to be aware of the symptoms of bladder cancer following a $9 billion judgment against the drug company to compensate a single bladder cancer victim.

According to court testimony, the plaintiff took Actos for five years before he was diagnosed with bladder cancer in 2011. Also that year, the Food and Drug Administration (FDA) issued a warning that people who took Actos for a year were 40 percent more likely to develop bladder cancer.

The FDA ordered Takeda Pharmaceuticals to update the safety label of Actos to include a bladder cancer warning. The agency also advised diabetics who took the drug to be aware of signs and symptoms of bladder cancer.

Bladder cancer symptoms include blood or red color in urine, urgent need to urinate, pain with urination, or pain in the lower back or abdomen.

“It is always important for patients to understand the potential side effects of any medication they are taking, but for people on Actos, knowing the signs of bladder cancer could be life-saving,” says Cancer Monthly’s Managing Editor Alex Strauss. “In addition, these people could have a legal recourse they are unaware of.”

Cancer Monthly advises people who took Actos and are diagnosed with bladder cancer to speak with an experienced attorney to determine their legal options. Currently, lawyers with Beasley Allen Law Firm are investigating cases of bladder cancer with Actos and are available for a consultation.

Source: PR Web